IPP Bureau
Ashland launches Perfectyl to rock skin perfection without injection
By IPP Bureau - December 04, 2023
Multi-ethnic innovation helps all complexions appear clearer and more uniform
AstraZeneca Pharma India receives permission from CDSCO to import new drug
By IPP Bureau - December 04, 2023
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
India joins Executive Committee of Codex Alimentarius Commission
By IPP Bureau - December 03, 2023
India had proposed for setting up the global standards for millets
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
By IPP Bureau - December 03, 2023
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application
By IPP Bureau - December 03, 2023
The new ECO grade is made using renewable feedstock
Tele-MANAS Cell established at Armed Forces Medical College, Pune
By IPP Bureau - December 02, 2023
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
AIIA initiates training programme on latent tuberculosis infections
By IPP Bureau - December 02, 2023
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister
By IPP Bureau - December 02, 2023
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
Venus Remedies granted market authorizations in Saudi Arabia and Philippines
By IPP Bureau - December 02, 2023
These regulatory approvals signify a significant milestone for Venus Remedies Limited
AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
By IPP Bureau - December 02, 2023
Currently, Venkat is Lead – Market Access, India at Pfizer
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
By IPP Bureau - December 02, 2023
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Strides launches Icosapent Ethyl Acid Soft Gel capsules in partnership with Amneal
By IPP Bureau - December 02, 2023
The product has been in-licensed from Strides and will be commercialized by Amneal
USFDA inspection at Alkem Laboratories API manufacturing facility located at Mandva
By IPP Bureau - December 02, 2023
The company has received Form 483 with three observations
Biocon Biologics completes Integration of Viatris' Biosimilar business
By IPP Bureau - December 01, 2023
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension
By IPP Bureau - December 01, 2023
The product is expected to be launched in FY25
